Core Viewpoint - Meikang Bio (300439.SZ) has recently obtained the Medical Device Registration Certificate for in vitro diagnostic reagents from the Zhejiang Provincial Drug Administration, which is expected to enhance the company's product line in the field of blood coagulation diagnostics and positively impact its future operations [1] Group 1 - The product name is Anti-Xa Test Kit (Colorimetric Substrate Method) [1] - The acquisition of the registration certificate enriches the company's product offerings in the in vitro diagnostic blood coagulation niche [1] - This development is anticipated to improve the company's core competitiveness and market expansion capabilities [1]